Vivos Therapeutics Inc

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Vivos Therapeutics Inc (VVOS) SEC filings

Vivos Therapeutics Inc (VVOS) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported VVOS revenue for 2025-12-31 was $17.4M. Net income was -$21.2M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VVOS currently screens at market cap $7.1M. The VVOS filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Vivos Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for VVOS — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

VVOS SEC filings FAQ

What is the latest VVOS SEC filing?

The latest cached Vivos Therapeutics Inc (VVOS) filing on this page is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/vvos

What is the latest VVOS filing accession number?

The latest cached Vivos Therapeutics Inc (VVOS) accession number on this page is 0001493152-26-047158. Filing: https://lician.com/sec/vvos/0001493152-26-047158

Which item codes are on the latest VVOS filing?

Cached item codes on the latest Vivos Therapeutics Inc (VVOS) 8-K are 1.01, 7.01, 8.01, 9.01.

How many VVOS SEC filings are listed on this page?

This page lists 8 cached Vivos Therapeutics Inc (VVOS) SEC filings. Filings: https://lician.com/sec/vvos

What events are listed on the VVOS SEC page?

Cached event headlines on this Vivos Therapeutics Inc (VVOS) SEC page: "VVOS earnings". Events: https://lician.com/sec/vvos

What are VVOS's latest revenue and net income?

Latest cached Vivos Therapeutics Inc (VVOS) revenue for Dec 31, 2025 was $17.4M. Net income was -$21.2M. Statements: https://lician.com/financials/vvos